PCVX
Vaxcyte, Inc.
Clinical-stage vaccine company developing conjugate and novel protein vaccines
CUSIP: 92243G108HealthcareUS1 holder
Total Value
$42.61M
Total Shares
1.31M
Net Share Change
+102.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$42.61M1.31M shares
ADD+102.5K(+8.5%)